Lymphocyte Development: Integration of DNA Damage Response Signaling

Advances in Immunology

Volumn 116, Issue , 2012, Pages 175-204

  Bednarski, Jeffrey J ^a   Sleckman, Barry P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage responses; IL 7; Lymphocytes; NHEJ; Pre BCR; RAG

Indexed keywords

ATM PROTEIN; CELL PROTEIN; DNA; DNA DEPENDENT PROTEIN KINASE; INTERLEUKIN 7 RECEPTOR; PRE B CELL RECEPTOR; RAG PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE ANTIGEN RECEPTOR GENE; CELL CYCLE G1 PHASE; CELL SPECIFICITY; CELL SURVIVAL; CYTOKINE RESPONSE; DNA CLEAVAGE; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENOTOXICITY; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN LIGHT CHAIN GENE; LYMPHOCYTE ANTIGEN RECEPTOR GENE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPOIESIS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VDJ RECOMBINATION;

EID: 84867341822     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394300-2.00006-5     Document Type: Chapter

References (171)

1. Agrawal A., Schatz D.G. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell 1997, 89:43-53.
2. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997, 89:1033-1041.
3. Allende M.L., Tuymetova G., Lee B.G., Bonifacino E., Wu Y.P., Proia R.L. S1P1 receptor directs the release of immature B cells from bone marrow into blood. The Journal of Experimental Medicine 2009, 207:1113-1124.
4. Amaravadi R., Thompson C.B. The survival kinases Akt and Pim as potential pharmacological targets. The Journal of Clinical Investigation 2005, 115:2618-2624.
5. Amin R.H., Schlissel M.S. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nature Immunology 2008, 9:613-622.
6. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
7. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998, 281:1674-1677.
8. Bankovich A.J., Raunser S., Juo Z.S., Walz T., Davis M.M., Garcia K.C. Structural insight into pre-B cell receptor function. Science 2007, 316:291-294.
9. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 1996, 86:159-171.
10. Basu S., Rosenzweig K.R., Youmell M., Price B.D. The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochemical and Biophysical Research Communications 1998, 247:79-83.
11. Bednarski J.J., Nickless A., Bhattacharya D., Amin R.H., Schlissel M.S., Sleckman B.P. RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation. The Journal of Experimental Medicine 2012, 209:11-17.
12. Bergman Y. Allelic exclusion in B and T lymphopoiesis. Seminars in Immunology 1999, 11:319-328.
13. Bertolino E., Reddy K., Medina K.L., Parganas E., Ihle J., Singh H. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nature Immunology 2005, 6:836-843.
14. Boehme K.A., Kulikov R., Blattner C. p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:7785-7790.
15. Brady B.L., Steinel N.C., Bassing C.H. Antigen receptor allelic exclusion: An update and reappraisal. Journal of Immunology 2010, 185:3801-3808.
16. Bredemeyer A.L., Helmink B.A., Innes C.L., Calderon B., McGinnis L.M., Mahowald G.K., et al. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 2008, 456:819-823.
17. Bredemeyer A.L., Sharma G.G., Huang C.Y., Helmink B.A., Walker L.M., Khor K.C., et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 2006, 442:466-470.
18. Callen E., Jankovic M., Wong N., Zha S., Chen H.T., Difilippantonio S., et al. Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Molecular Cell 2009, 34:285-297.
19. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238.
20. Casellas R., Shih T.A., Kleinewietfeld M., Rakonjac J., Nemazee D., Rajewsky K., et al. Contribution of receptor editing to the antibody repertoire. Science 2001, 291:1541-1544.
21. Chen H.T., Bhandoola A., Difilippantonio M.J., Zhu J., Brown M.J., Tai X., et al. Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX. Science 2000, 290:1962-1965.
22. Chen Y.Y., Wang L.C., Huang M.S., Rosenberg N. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes & Development 1994, 8:688-697.
23. Chou W.C., Levy D.E., Lee C.K. STAT3 positively regulates an early step in B-cell development. Blood 2006, 108:3005-3011.
24. Cooper A.B., Sawai C.M., Sicinska E., Powers S.E., Sicinski P., Clark M.R., et al. A unique function for cyclin D3 in early B cell development. Nature Immunology 2006, 7:489-497.
25. Corfe S.A., Paige C.J. The many roles of IL-7 in B cell development; Mediator of survival, proliferation and differentiation. Seminars in Immunology 2012, 24:198-208.
26. D'Amours D., Jackson S.P. The Mre11 complex: At the crossroads of dna repair and checkpoint signalling. Nature Reviews. Molecular Cell Biology 2002, 3:317-327.
27. Deriano L., Stracker T.H., Baker A., Petrini J.H., Roth D.B. Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. Molecular Cell 2009, 34:13-25.
28. Derudder E., Cadera E.J., Vahl J.C., Wang J., Fox C.J., Zha S., et al. Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals. Nature Immunology 2009, 10:647-654.
29. Desiderio S., Lin W.C., Li Z. The cell cycle and V(D)J recombination. Current Topics in Microbiology and Immunology 1996, 217:45-59.
30. Digweed M., Sperling K. Nijmegen breakage syndrome: Clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst) 2004, 3:1207-1217.
31. DiSanto J.P., Guy-Grand D., Fisher A., Tarakhovsky A. Critical role for the common cytokine receptor gamma chain in intrathymic and peripheral T cell selection. The Journal of Experimental Medicine 1996, 183:1111-1118.
32. Domen J., van der Lugt N.M., Acton D., Laird P.W., Linders K., Berns A. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. The Journal of Experimental Medicine 1993, 178:1665-1673.
33. Durocher D., Jackson S.P. DNA-PK, ATM and ATR as sensors of DNA damage: Variations on a theme?. Current Opinion in Cell Biology 2001, 13:225-231.
34. Elkon R., Rashi-Elkeles S., Lerenthal Y., Linhart C., Tenne T., Amariglio N., et al. Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biology 2005, 6:R43.
35. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:13084-13089.
36. Erlandsson L., Licence S., Gaspal F., Lane P., Corcoran A.E., Martensson I.L. Both the pre-BCR and the IL-7Ralpha are essential for expansion at the pre-BII cell stage in vivo. European Journal of Immunology 2005, 35:1969-1976.
37. Fedele M., Fidanza V., Battista S., Pentimalli F., Klein-Szanto A.J., Visone R., et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Research 2006, 66:2536-2543.
38. Feng C., Woodside K.J., Vance B.A., El-Khoury D., Canelles M., Lee J., et al. A potential role for CD69 in thymocyte emigration. International Immunology 2002, 14:535-544.
39. Fernandez-Capetillo O., Lee A., Nussenzweig M., Nussenzweig A. H2AX: The histone guardian of the genome. DNA Repair (Amst) 2004, 3:959-967.
40. Fleming H.E., Paige C.J. Pre-B cell receptor signaling mediates selective response to IL-7 at the Pro-B to Pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 2001, 15:521-531.
41. Flemming A., Brummer T., Reth M., Jumaa H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nature Immunology 2003, 4:38-43.
42. Fox C.J., Hammerman P.S., Cinalli R.M., Master S.R., Chodosh L.A., Thompson C.B. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes & Development 2003, 17:1841-1854.
43. Fugmann S.D., Lee A.I., Shockett P.E., Villey I.J., Schatz D.G. The RAG proteins and V(D)J recombination: Complexes, ends, and transposition. Annual Review of Immunology 2000, 18:495-527.
44. Galkina E., Florey O., Zarbock A., Smith B.R., Preece G., Lawrence M.B., et al. T lymphocyte rolling and recruitment into peripheral lymph nodes is regulated by a saturable density of L-selectin (CD62L). European Journal of Immunology 2007, 37:1243-1253.
45. Gapud E.J., Dorsett Y., Yin B., Callen E., Bredemeyer A., Mahowald G.K., et al. Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2022-2027.
46. Gatei M., Jakob B., Chen P., Kijas A.W., Becherel O.J., Gueven N., et al. ATM protein-dependent phosphorylation of Rad50 protein regulates DNA repair and cell cycle control. The Journal of Biological Chemistry 2011, 286:31542-31556.
47. Gatei M., Young D., Cerosaletti K.M., Desai-Mehta A., Spring K., Kozlov S., et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nature Genetics 2000, 25:115-119.
48. Gellert M. V(D)J recombination: Rag proteins, repair factors, and regulation. Annual Review of Biochemistry 2002, 71:101-132.
49. Goetz C.A., Harmon I.R., O'Neil J.J., Burchill M.A., Farrar M.A. STAT5 activation underlies IL7 receptor-dependent B cell development. Journal of Immunology 2004, 172:4770-4778.
50. Goodarzi A.A., Yu Y., Riballo E., Douglas P., Walker S.A., Ye R., et al. DNA-PK autophosphorylation facilitates Artemis endonuclease activity. The EMBO Journal 2006, 25:3880-3889.
51. Gorman J.R., Alt F.W. Regulation of immunoglobulin light chain isotype expression. Advances in Immunology 1998, 69:113-181.
52. Grawunder U., Haasner D., Melchers F., Rolink A. Rearrangement and expression of kappa light chain genes can occur without mu heavy chain expression during differentiation of pre-B cells. International Immunology 1993, 5:1609-1618.
53. Guidos C.J., Williams C.J., Grandal I., Knowles G., Huang M.T., Danska J.S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes & Development 1996, 10:2038-2054.
54. Gurley K.E., Kemp C.J. Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. Current Biology 2001, 11:191-194.
55. Halverson R., Torres R.M., Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nature Immunology 2004, 5:645-650.
56. Hayden M.S., Ghosh S. NF-kappaB, the first quarter-century: Remarkable progress and outstanding questions. Genes & Development 2012, 26:203-234.
57. Helmink B.A., Bredemeyer A.L., Lee B.S., Huang C.Y., Sharma G.G., Walker L.M., et al. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. The Journal of Experimental Medicine 2009, 206:669-679.
58. Helmink B.A., Sleckman B.P. The Response to and Repair of RAG-Mediated DNA Double-Strand Breaks. Annual Review of Immunology 2012, 30:175-202.
59. Herzog S., Hug E., Meixlsperger S., Paik J.H., DePinho R.A., Reth M., et al. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nature Immunology 2008, 9:623-631.
60. Herzog S., Reth M., Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nature Reviews. Immunology 2009, 9:195-205.
61. Hewitt S.L., Yin B., Ji Y., Chaumeil J., Marszalek K., Tenthorey J., et al. RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci. Nature Immunology 2009, 10:655-664.
62. Hiom K., Gellert M. Assembly of a 12/23 paired signal complex: A critical control point in V(D)J recombination. Molecular Cell 1998, 1:1011-1019.
63. Hoelbl A., Kovacic B., Kerenyi M.A., Simma O., Warsch W., Cui Y., et al. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 2006, 107:4898-4906.
64. Hur G.M., Lewis J., Yang Q., Lin Y., Nakano H., Nedospasov S., et al. The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes & Development 2003, 17:873-882.
65. Janssens S., Tinel A., Lippens S., Tschopp J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell 2005, 123:1079-1092.
66. Jimi E., Phillips R.J., Rincon M., Voll R., Karasuyama H., Flavell R., et al. Activation of NF-kappaB promotes the transition of large, CD43+ pre-B cells to small, CD43- pre-B cells. International Immunology 2005, 17:815-825.
67. Jin H.S., Lee D.H., Kim D.H., Chung J.H., Lee S.J., Lee T.H. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Research 2009, 69:1782-1791.
68. Johnson K., Hashimshony T., Sawai C.M., Pongubala J.M., Skok J.A., Aifantis I., et al. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 2008, 28:335-345.
69. Jones J.M., Gellert M. Intermediates in V(D)J recombination: A stable RAG1/2 complex sequesters cleaved RSS ends. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12926-12931.
70. Jung D., Giallourakis C., Mostoslavsky R., Alt F.W. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annual Review of Immunology 2006, 24:541-570.
71. Kashatus D., Cogswell P., Baldwin A.S. Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes & Development 2006, 20:225-235.
72. Khanna K.K., Keating K.E., Kozlov S., Scott S., Gatei M., Hobson K., et al. ATM associates with and phosphorylates p53: Mapping the region of interaction. Nature Genetics 1998, 20:398-400.
73. Kistler B., Rolink A., Marienfeld R., Neumann M., Wirth T. Induction of nuclear factor-kappa B during primary B cell differentiation. Journal of Immunology 1998, 160:2308-2317.
74. Kobayashi J., Antoccia A., Tauchi H., Matsuura S., Komatsu K. NBS1 and its functional role in the DNA damage response. DNA Repair (Amst) 2004, 3:855-861.
75. Kovanen P.E., Leonard W.J. Cytokines and immunodeficiency diseases: Critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunological Reviews 2004, 202:67-83.
76. Lavin M.F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annual Review of Immunology 1997, 15:177-202.
77. Lazorchak A.S., Liu D., Facchinetti V., Di Lorenzo A., Sessa W.C., Schatz D.G., et al. Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. Molecular Cell 2010, 39:433-443.
78. Lee J.H., Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 2004, 304:93-96.
79. Lee J.H., Paull T.T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 2005, 308:551-554.
80. Li G., Alt F.W., Cheng H.L., Brush J.W., Goff P.H., Murphy M.M., et al. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Molecular Cell 2008, 31:631-640.
81. Li W.Q., Jiang Q., Khaled A.R., Keller J.R., Durum S.K. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. The Journal of Biological Chemistry 2004, 279:29160-29166.
82. Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annual Review of Biochemistry 2010, 79:181-211.
83. Lim D.S., Kim S.T., Xu B., Maser R.S., Lin J., Petrini J.H., et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 2000, 404:613-617.
84. Liu X., Jiang W., Dubois R.L., Yamamoto K., Wolner Z., Zha S. Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:3903-3908.
85. Liu L., Kwak Y.T., Bex F., Garcia-Martinez L.F., Li X.H., Meek K., et al. DNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding properties. Molecular and Cellular Biology 1998, 18:4221-4234.
86. Lu R., Medina K.L., Lancki D.W., Singh H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes & Development 2003, 17:1703-1708.
87. Ma Y., Pannicke U., Schwarz K., Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 2002, 108:781-794.
88. Ma S., Pathak S., Mandal M., Trinh L., Clark M.R., Lu R. Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Molecular and Cellular Biology 2010, 30:4149-4158.
89. Mabb A.M., Wuerzberger-Davis S.M., Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nature Cell Biology 2006, 8:986-993.
90. Mainville C.A., Parmar K., Unnikrishnan I., Gong L., Raffel G.D., Rosenberg N. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain. Journal of Virology 2001, 75:1816-1823.
91. Malin S., McManus S., Busslinger M. STAT5 in B cell development and leukemia. Current Opinion in Immunology 2010, 22:168-176.
92. Malin S., McManus S., Cobaleda C., Novatchkova M., Delogu A., Bouillet P., et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nature Immunology 2010, 11:171-179.
93. Mandal M., Powers S.E., Ochiai K., Georgopoulos K., Kee B.L., Singh H., et al. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nature Immunology 2009, 10:1110-1117.
94. Mannironi C., Bonner W.M., Hatch C.L. H2A.X. a histone isoprotein with a conserved C-terminal sequence, is encoded by a novel mRNA with both DNA replication type and polyA 3' processing signals. Nucleic Acids Research 1989, 17:9113-9126.
95. Maraskovsky E., O'Reilly L.A., Teepe M., Corcoran L.M., Peschon J.J., Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell 1997, 89:1011-1019.
96. Maraskovsky E., Peschon J.J., McKenna H., Teepe M., Strasser A. Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cells. International Immunology 1998, 10:1367-1375.
97. Marshall A.J., Fleming H.E., Wu G.E., Paige C.J. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. Journal of Immunology 1998, 161:6038-6045.
98. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
99. Max E.E. Immunoglobulins: molecular genetics. Fundamental immunology 2008, 192-236. Lippincott Williams & Wilkins, Philadelphia. W.E. Paul (Ed.).
100. McCarthy K.M., McDevit D., Andreucci A., Reeves R., Nikolajczyk B.S. HMGA1 co-activates transcription in B cells through indirect association with DNA. The Journal of Biological Chemistry 2003, 278:42106-42114.
101. Meek K., Dang V., Lees-Miller S.P. DNA-PK: The means to justify the ends?. Advances in Immunology 2008, 99:33-58.
102. Mikkers H., Nawijn M., Allen J., Brouwers C., Verhoeven E., Jonkers J., et al. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Molecular and Cellular Biology 2004, 24:6104-6115.
103. Milne C.D., Zhang Y., Paige C.J. Stromal cells attract B-cell progenitors to promote B-cell-B-cell contact and maturation. Scandinavian Journal of Immunology 2005, 62(Suppl 1):67-72.
104. Miyamoto S. Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Research 2011, 21:116-130.
105. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Negishi I., et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995, 267:1506-1510.
106. Muljo S.A., Schlissel M.S. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nature Immunology 2003, 4:31-37.
107. Nacht M., Strasser A., Chan Y.R., Harris A.W., Schlissel M., Bronson R.T., et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes & Development 1996, 10:2055-2066.
108. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nature Reviews. Immunology 2006, 6:728-740.
109. Nemazee D., Kouskoff V., Hertz M., Lang J., Melamed D., Pape K., et al. B-cell-receptor-dependent positive and negative selection in immature B cells. Current Topics in Microbiology and Immunology 2000, 245:57-71.
110. Nosaka T., van Deursen J.M., Tripp R.A., Thierfelder W.E., Witthuhn B.A., McMickle A.P., et al. Defective lymphoid development in mice lacking Jak3. Science 1995, 270:800-802.
111. Ochiai K., Maienschein-Cline M., Mandal M., Triggs J.R., Bertolino E., Sciammas R., et al. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nature Immunology 2012, 13:300-307.
112. Oettinger M.A. V(D)J recombination: On the cutting edge. Current Opinion in Cell Biology 1999, 11:325-329.
113. Oksenych V., Alt F.W., Kumar V., Schwer B., Wesemann D.R., Hansen E., et al. Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombination and DNA repair. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:2455-2460.
114. Park S.Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995, 3:771-782.
115. Pearce G., Angeli V., Randolph G.J., Junt T., von Andrian U., Schnittler H.J., et al. Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs. Nature Immunology 2006, 7:827-834.
116. Pedraza-Alva G., Koulnis M., Charland C., Thornton T., Clements J.L., Schlissel M.S., et al. Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. The EMBO Journal 2006, 25:763-773.
117. Pellegrini M., Celeste A., Difilippantonio S., Guo R., Wang W., Feigenbaum L., et al. Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature 2006, 443:222-225.
118. Pereira J.P., Xu Y., Cyster J.G. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. PloS One 2010, 5:e9277.
119. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. The Journal of Experimental Medicine 1994, 180:1955-1960.
120. Puel A., Ziegler S.F., Buckley R.H., Leonard W.J. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nature Genetics 1998, 20:394-397.
121. Rashi-Elkeles S., Elkon R., Weizman N., Linhart C., Amariglio N., Sternberg G., et al. Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene 2006, 25:1584-1592.
122. Reinhardt H.C., Yaffe M.B. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Current Opinion in Cell Biology 2009, 21:245-255.
123. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 1998, 93:373-383.
124. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. The Journal of Biological Chemistry 1998, 273:5858-5868.
125. Rolink A., Kudo A., Karasuyama H., Kikuchi Y., Melchers F. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. The EMBO Journal 1991, 10:327-336.
126. Rolink A., Streb M., Melchers F. The kappa/lambda ratio in surface immunoglobulin molecules on B lymphocytes differentiating from DHJH-rearranged murine pre-B cell clones in vitro. European Journal of Immunology 1991, 21:2895-2898.
127. Rooney S., Chaudhuri J., Alt F.W. The role of the non-homologous end-joining pathway in lymphocyte development. Immunological Reviews 2004, 200:115-131.
128. Rooney S., Sekiguchi J., Zhu C., Cheng H.L., Manis J., Whitlow S., et al. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Molecular Cell 2002, 10:1379-1390.
129. Rosen S.D. Ligands for L-selectin: Homing, inflammation, and beyond. Annual Review of Immunology 2004, 22:129-156.
130. Rouse J., Jackson S.P. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002, 297:547-551.
131. Saijo K., Schmedt C., Su I.H., Karasuyama H., Lowell C.A., Reth M., et al. Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nature Immunology 2003, 4:274-279.
132. Savic V., Yin B., Maas N.L., Bredemeyer A.L., Carpenter A.C., Helmink B.A., et al. Formation of dynamic gamma-H2AX domains along broken DNA strands is distinctly regulated by ATM and MDC1 and dependent upon H2AX densities in chromatin. Molecular Cell 2009, 34:298-310.
133. Schebesta M., Pfeffer P.L., Busslinger M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 2002, 17:473-485.
134. Schild-Poulter C., Shih A., Tantin D., Yarymowich N.C., Soubeyrand S., Sharp P.A., et al. DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage. Oncogene 2007, 26:3980-3988.
135. Schwab S.R., Cyster J.G. Finding a way out: Lymphocyte egress from lymphoid organs. Nature Immunology 2007, 8:1295-1301.
136. Sekiguchi J., Ferguson D.O., Chen H.T., Yang E.M., Earle J., Frank K., et al. Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:3243-3248.
137. Sen R., Oltz E. Genetic and epigenetic regulation of IgH gene assembly. Current Opinion in Immunology 2006, 18:237-242.
138. Shaw A.C., Swat W., Ferrini R., Davidson L., Alt F.W. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. The Journal of Experimental Medicine 1999, 189:123-129.
139. Sherman M.H., Kuraishy A.I., Deshpande C., Hong J.S., Cacalano N.A., Gatti R.A., et al. AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling. Molecular Cell 2010, 39:873-885.
140. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. Nature Reviews. Cancer 2003, 3:155-168.
141. Shiow L.R., Rosen D.B., Brdickova N., Xu Y., An J., Lanier L.L., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.
142. Smith G.C., Jackson S.P. The DNA-dependent protein kinase. Genes & Development 1999, 13:916-934.
143. Spanopoulou E., Roman C.A.J., Corcoran L., Schilissel M.S., Silver D.P., Nemazee D., et al. Functional immunoglobulin transgenes guide ordered B cell differentiation in RAG-1 deficient mice. Genes & Development 1994, 8:1030-1042.
144. Stanhope-Baker P., Hudson K.M., Shaffer A.L., Constantinescu A., Schlissel M.S. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 1996, 85:887-897.
145. Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Lobrich M., Jeggo P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Research 2004, 64:2390-2396.
146. Stracker T.H., Petrini J.H. The MRE11 complex: Starting from the ends. Nature Reviews. Molecular Cell Biology 2011, 12:90-103.
147. Subramanian H., Grailer J.J., Ohlrich K.C., Rymaszewski A.L., Loppnow J.J., Kodera M., et al. Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine. Journal of Immunology 2012, 188:3223-3236.
148. Suzuki K., Nakajima H., Saito Y., Saito T., Leonard W.J., Iwamoto I. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: Comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice. International Immunology 2000, 12:123-132.
149. Taylor A.M., Groom A., Byrd P.J. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amst) 2004, 3:1219-1225.
150. Thomis D.C., Gurniak C.B., Tivol E., Sharpe A.H., Berg L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995, 270:794-797.
151. Tokoyoda K., Egawa T., Sugiyama T., Choi B.I., Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20:707-718.
152. Tomimatsu N., Mukherjee B., Burma S. Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. EMBO Reports 2009, 10:629-635.
153. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
154. van der Burg M., Ijspeert H., Verkaik N.S., Turul T., Wiegant W.W., Morotomi-Yano K., et al. A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. The Journal of Clinical Investigation 2009, 119:91-98.
155. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. The Journal of Experimental Medicine 1995, 181:1519-1526.
156. Vousden K.H., Prives C. Blinded by the light: The growing complexity of p53. Cell 2009, 137:413-431.
157. Weterings E., Chen D.J. DNA-dependent protein kinase in nonhomologous end joining: A lock with multiple keys?. The Journal of Cell Biology 2007, 179:183-186.
158. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., Alt F.W. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995, 3:521-530.
159. Wu X., Ranganathan V., Weisman D.S., Heine W.F., Ciccone D.N., O'Neill T.B., et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 2000, 405:477-482.
160. Wu Z.H., Shi Y., Tibbetts R.S., Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006, 311:1141-1146.
161. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes & Development 1996, 10:2411-2422.
162. Xu S., Lee K.G., Huo J., Kurosaki T., Lam K.P. Combined deficiencies in Bruton tyrosine kinase and phospholipase Cgamma2 arrest B-cell development at a pre-BCR+ stage. Blood 2007, 109:3377-3384.
163. Yancopoulos G.D., DePinho R.A., Zimmerman K.A., Lutzker S.G., Rosenberg N., Alt F.W. Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. The EMBO Journal 1986, 5:3259-3266.
164. Yao Z., Cui Y., Watford W.T., Bream J.H., Yamaoka K., Hissong B.D., et al. Stat5a/b are essential for normal lymphoid development and differentiation. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:1000-1005.
165. You Z., Bailis J.M., Johnson S.A., Dilworth S.M., Hunter T. Rapid activation of ATM on DNA flanking double-strand breaks. Nature Cell Biology 2007, 9:1311-1318.
166. You Z., Chahwan C., Bailis J., Hunter T., Russell P. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. Molecular and Cellular Biology 2005, 25:5363-5379.
167. Youle R.J., Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nature Reviews. Molecular Cell Biology 2008, 9:47-59.
168. Young F., Ardman B., Shinkai Y., Lansford R., Blackwell T.K., Mendelsohn M., et al. Influence of immunoglobulin heavy and light chain expression on B cell differentiation. Genes & Development 1994, 8:1043-1057.
169. Zha S., Guo C., Boboila C., Oksenych V., Cheng H.L., Zhang Y., et al. ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks. Nature 2011, 469:250-254.
170. Zha S., Jiang W., Fujiwara Y., Patel H., Goff P.H., Brush J.W., et al. Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2028-2033.
171. Zhou B.B., Elledge S.J. The DNA damage response: Putting checkpoints in perspective. Nature 2000, 408:433-439.